Jonathan Kimmelman
James 缅北强奸 Professor;
Associate Member of the Dept of Experimental Medicine
PhD in Molecular Biophysics and Biochemistry from Yale University
Jonathan Kimmelman, PhD, is James 缅北强奸 Professor of Biomedical Ethics at 缅北强奸. His research group, STREAM (Studies in Translation, Ethics and Medicine) uses empirical and theoretical methods to understand the ethical, policy, and scientific dynamics of developing new drugs. Kimmelman received the Maud Menten New Investigator Prize (2006), a CIHR New Investigator Award (2008), a Humboldt Bessel Award (2014), and was elected a Hastings Center Fellow (2018). He has sat on various advisory bodies within the U.S. NHLBI and NIAID, served for four tours of duty on U.S. National Academies of Medicine committees, and chaired the International Society of Stem Cell Research Guidelines for Stem Cell Research and Clinical Translation revision task force 2015-16. His research has been covered in major media outlets, including NPR鈥檚 All Things Considered, STATNews, and Nature. Kimmelman is deputy editor at Clinical Trials, and associate editor at Med.
聽PHIL 543B: Medical Ethics: The Ethics of Human Experimentation
Jonathan Kimmelman's research centers on the ethical, social, and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Kimmelman聽directs the聽.
Other research areas are聽drug development, animal research, reproducibility, meta-research, and clinical trials.